Browsing Tag
NASDAQ
348 posts
Caris Life Sciences (NASDAQ: CAI) says final Achieve 1 data strengthens the case for Caris Detect, but can MCED execution close the gap?
Caris Life Sciences says final Achieve 1 data strengthens Caris Detect. Read why the MCED opportunity looks bigger, and why execution risk still matters.
April 1, 2026
What Datavault AI Inc.’s Coppercoin launch means for critical minerals finance and investor access (NASDAQ: DVLT)
Find out what Datavault AI Inc.’s Coppercoin launch could mean for copper investing, mining finance, and DVLT’s long-term platform strategy.
March 31, 2026
New Fortress Energy Brazil secures long-term TGS terminal lease targeting $50m EBITDA by 2027
New Fortress Energy Brazil secures a long-term TGS terminal lease targeting $50m EBITDA by 2027. Read what it means for BrazilCo and southern Brazil's gas market.
March 31, 2026
BlackRock backs IQM Quantum Computers with €50m as Finnish firm targets US listing at $1.8bn valuation
BlackRock commits EUR 50M to IQM Quantum Computers ahead of its USD 1.8B Nasdaq listing. Read the full strategic and market analysis. | Business News Today
March 31, 2026
Can Autozi Internet Technology (Global) Ltd. rebuild valuation fast enough to avoid delisting risk?
Autozi faces Nasdaq compliance risk as valuation dips below $50M. Find out what this means for investors and whether recovery is still possible.
March 29, 2026
What Greenland Energy Company’s rig agreement reveals about frontier oil economics and execution risk (NASDAQ: GLND)
Find out how Greenland Energy Company’s Arctic drilling deal could reshape frontier oil exploration economics and investor sentiment today.
March 29, 2026
Can Rocket Lab Corporation turn one European Space Agency mission into a bigger geopolitical and commercial advantage? (NASDAQ: RKLB)
Rocket Lab Corporation’s ESA mission could be bigger than a launch win. Read how it may reshape sovereign space access and investor sentiment now.
March 29, 2026
Incyte (NASDAQ: INCY) moves closer to an hidradenitis suppurativa launch as 54-week povorcitinib data hold up
Incyte Corporation’s new 54-week povorcitinib data could reshape hidradenitis suppurativa treatment. Read what it means for INCY now.
March 29, 2026
What NN, Inc.’s plating acquisition signals about its shift toward power infrastructure markets
Discover how NN, Inc. is targeting grid and data center growth through a strategic acquisition—and what it means for margins, risk, and future upside.
March 27, 2026
How Cambium Networks Corporation’s Nasdaq delisting reshapes investor risk, liquidity, and valuation outlook (NASDAQ: CMBM)
Cambium Networks Corporation faces Nasdaq delisting. Discover what it means for liquidity, investor risk, and the company’s future path.
March 26, 2026